Skip to main content Accessibility help
Instructions for authors

All submissions to the Journal should be made via Editorial Manager

JRP uses a single-blind peer review process. Submitted manuscripts are reviewed by a member of the Editorial Board and two reviewers.

A paper is accepted for publication on the understanding that it has not been submitted simultaneously to another journal.

Papers that contain the results of human and/or animal studies will only be accepted for publication if it is made clear that a high standard of ethics was applied in carrying out the investigations. In the case of invasive studies of humans, authors will be asked to confirm that the research protocol was approved by a local ethics committee.

The Editor reserves the right to make editorial and literary corrections. Any opinions expressed or policies advocated do not necessarily reflect the opinions or policies of the Editor.


The policy of Journal of Radiotherapy in Practice is that authors (or in some cases their employers) retain copyright and grant Cambridge University Press a licence to publish their work. In the case of gold open access articles this is a non-exclusive licence. Authors must complete and return an author publishing agreement form as soon as their article has been accepted for publication; the journal is unable to publish the article without this. Please download the appropriate publishing agreement here.

For open access articles, the form also sets out the Creative Commons licence under which the article is made available to end users: a fundamental principle of open access is that content should not simply be accessible but should also be freely re-usable. Articles will be published under a Creative Commons Attribution license (CC-BY) by default. This means that the article is freely available to read, copy and redistribute, and can also be adapted (users can “remix, transform, and build upon” the work) for any commercial or non-commercial purpose, as long as proper attribution is given. Authors can, in the publishing agreement form, choose a different kind of Creative Commons license (including those prohibiting non-commercial and derivative use) if they prefer.

Presentation of Typescripts

Please follow instructions found at Editorial Manager submission site. Please submit your manuscript in Word format.

  • Turn off the automatic hyphenation option. Only use hyphens when they are part of a word.
  • Never use the letter 'I' for the number 1. Never use the letter 'O' for the number 0.
  • Always insert a space between a number and unit, e.g. 5 mm.
  • Do not indent lists. However, if preparing a list within a list, use a tab, not a space to indent the subsets. Bullets, numbers, alphabet characters or dashes may be used but please use rationally and consistently.
  • Submissions should use line numbering.
Full papers

Papers should be set out as follows, with each section beginning on a separate page; title page, summary, text, acknowledgements, references, tables, captions to illustrations. Papers should not exceed 3,500 words, inclusive of references.

Title page. The title page should give the following information: 1) title of the article; 2) initial and name of each author, with the highest academic degree(s); 3) name and address of the department or institution to which the work should be attributed; 4) names, address, telephone and fax number of the author responsible for correspondence and to whom request for reprints should be sent and 5) sources of support in the form of grants.

Abstract. This should consist of not more than 200 words summarising the contents of the article, and should include the following 4 headings: aim, materials and methods, results, and findings.

Text. Headings should be appropriate to the nature of the paper. In general those for experimental papers should follow the usual conventions. Other papers can be subdivided as the author desires; the use of headings enhances readability. Do not use 'he', 'his', etc. where the sex of the person is unknown; say, 'the patient' etc. Avoid inelegant alternatives as 'he/she'. Patients should not automatically be designated as 'she' and the doctor as 'he'.

Acknowledgements. Here you may acknowledge individuals or organisations that provided advice and/or support (non-financial). Formal financial support and funding should be listed in the following section. The Acknowledgements should be placed after the main body of the text before Financial Support. If there are no Acknowledgements, the title should be inserted followed by "None". Papers that do not include an Acknowledgements section will not be reviewed.

Financial Support. Please provide details of the sources of financial support for all authors, including grant numbers. This is particularly important in the case of research that is supported by industry. Support from industry not only includes direct financial support for the study but also support in kind such as provision of medications, equipment, kits or reagents without charge or at reduced cost and provision of services such as statistical analysis. For example, "This work was supported by the Medical research Council (grant number XXXXXXX)". Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with "and" before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors' initials. For example, "This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)". Where no specific funding has been provided for research, please provide the following statement: "This research received no specific grant from any funding agency, commercial or not-for-profit sectors." The Financial Support statement should be placed after the Acknowledgements and before the Conflicts of Interest section. Papers that do not include a Financial Support statement will not be reviewed.

Conflicts of Interest. Conflict of interest exists when an author has interests that might inappropriately influence his or her judgement, even if that judgement is not influenced. Because of this, authors must disclose potentially conflicting interests so that others can make judgements about such effects. At the time of submission authors should disclose any financial arrangements or connections they may have that are pertinent to the submitted manuscript and that may be perceived as potentially biasing their paper. Non-financial interests that could be relevant in this context should also be disclosed. If no relevant interests exist, this should be stated. This requirement applies to all the authors of a paper and to all categories of papers including letters to the editor. The Conflicts of Interest section should be placed after Financial Support. If there are no interests to declare, the title should be inserted followed by "None". Papers that do not include a Conflict of Interest section will not be reviewed.

Ethical Standards. Where research involves human and/or animal experimentation, the following statements should be included (as applicable): "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation (please name) and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committees (please name) ." and "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guides on the care and use of laboratory animals (please name) and has been approved by the institutional committee (please name)." The Ethical Standards statement should be placed after the Conflicts of Interest section before the References. If the research does not involve human and/or animal experimentation, this statement should be omitted. Papers reporting the results of human and/or animal experimentation that do not contain an Ethical Standards statement will not be reviewed. For more information on the ethical standards and procedures of Cambridge Journals, please visit Cambridge Core.

For systematic reviews and meta-analyses, JRP requires completion of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist ( This policy includes all systematic reviews, including those for observational studies. A completed copy of the checklist should be submitted along with the manuscript, with page numbers noted as required. When a given item has not been addressed, authors must provide an explanation.

Editors and reviewers will not evaluate manuscripts based on the number of items checked off in the checklist. The purpose of the PRISMA guidelines is to recommend a critical set of items that should typically be reported in a manuscript. The guidelines are meant to improve transparency by helping authors improve the quality of their reporting. More clarity in reporting will facilitate review of your manuscript and increase its value to readers.

References. The accuracy of references is the responsibility of the author. References should be entered consecutively by Arabic numbers in parentheses in the text. The reference list should be listed in numerical order on a separate sheet in double or triple spacing. References to journals should include the author's name and initials (list all authors when six or fewer; when seven or more, list only the first three and add et al.), full title of the paper, journal's title abbreviated, using Index Medicus abbreviations, year of publication, volume number, first and last page numbers.

For example: Albert M J, Faruque S M, Ansaruzzaman M et al. Sharing of virulence-associated properties at the phenotypic and generic levels between enteropathogenic Escherichia coli and Hafnia alvei. J Med Microbiol 1992; 37: 310-314.

References to books should be set out as follows: Facklan P, R, Carey P, B. Streptococci and areococci. In: Lennetti E H (ed) Manual of Clinical Microbiology, 4th edn. Washington, D.C. American Society for Microbiology 1985: 156-157.

Case Reports

Case Reports which add important new information will be considered for publication. Articles published in this section should have no more than three authors, 1000 words, a summary (of about 60 words), 3–6 key words, two figures or tables, and 10 references.

Letters to the Editor

Readers are encouraged to write about any topic that relates to the Journal. Such letters will be published in a distinct section. They should be no longer than 500 words.


Reviews of recent developments are welcome. Authors are encouraged to contact the editor to determine the appropriateness for inclusion.

For systematic reviews and meta-analyses, the journal endorses the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement (see British Medical Journal (2009) 339, b2535). Such submissions should follow the PRISMA guidelines and authors should include the PRISMA checklist with their submission (see instructions above).


Tables. Tables should follow the style as demonstrated in issues to date, and be essential to the understanding of the text. Tables should have short descriptive titles and should be numbered (1, 2, 3 etc.) as they appear sequentially in the text. If only one Table is included, it should be referred to as Table. Submit each Table on a separate sheet of paper. All abbreviations and symbols should be defined in a footnote below the Table.

Figures. To ensure that your figures are reproduced to the highest possible standards, Cambridge Journals recommends the following formats and resolutions for supplying electronic figures. If you request colour figures in the printed version, you will be contacted by CCC-Rightslink who are acting on our behalf to collect Author Charges. Please follow their instructions in order to avoid any delay in the publication of your article.

Please ensure that your figures are saved at final publication size and are in our recommended file formats. Following these guidelines will result in high quality images being reproduced in both the print and the online versions of the journal.

Line artwork

Format: tif or eps

Colour mode: black and white (also known as 1-bit)

Resolution: 1200 dpi

Combination artwork (line/tone)

Format: tif or eps

Colour mode: grayscale (also known as 8-bit)

Resolution: 800 dpi

Black and white halftone artwork

Format: tif

Colour mode: grayscale (also known as 8-bit)

Resolution: 300 dpi

Colour halftone artwork

Format: tif

Colour mode: CMYK colour

Resolution: 300 dpi

If you require any further guidance on creating suitable electronic figures, please visit Here you will find extensive guidelines on preparing electronic figures and also have access to an online preflighting tool ( where you can check if your figures are suitable for reproduction.

Please ensure that all graphs are exclusively submitted as 2-dimensional images.

Photographs should have the magnification and details of staining techniques shown.

Where illustrations must include recognizable individuals, living or dead and of whatever age, great care must be taken to ensure that consent for publication has been given. If identifiable features are not essential to the illustration, please indicate where the illustration can be cropped. In cases where consent has not been obtained and recognizable features may appear, it will be necessary to retouch the features to mask the eyes or otherwise render the individual so not 'officially recognizable'.

Written permission to reproduce borrowed material (figures and tables) must be obtained from the original publisher and authors, and provided with the submission. Borrowed material should be acknowledged in the captions in this style: 'Reproduced by kind permission of … (publisher) from ... (reference)'.

Page proofs

Page proofs are sent to the author for checking. The proofs, with any minor corrections, must be returned within 48 hours of receipt. All typescripts undergo some editorial modifications, so it is important to read your proofs carefully.

Proprietary names

Proprietary names of drugs, instruments, etc, should be indicated by the use of initial capital letters.

Abbreviations and Units

Avoid abbreviations in the title and abstracts. All unusual abbreviations should be fully explained at their first occurrence in the text. All measurements should be expressed in metric units. For more detailed recommendations, authors may consult the Royal Society of Medicine publication entitled Units, Symbols and Abbreviations: A Guide for Biological and Medical Editors and Authors or USA equivalent.


Authors may purchase offprints if required. An offprint order form will be sent to the author with the page proofs.

Transparency and Openness Guidelines

The Journal of Radiotherapy in Practice believes in the importance of transparent and reproducible research. Where possible we encourage authors to make evidence, data, code, and other materials that underpin their findings available to readers. We also encourage authors to cite materials and data they have used in their research, alongside literature citations, to recognise the importance of all kinds of research outputs.

We encourage the use of Data Availability Statements to describe whether the materials that underpin research findings have been made available to readers, and if so, where.

When sharing materials, we recommend using a dedicated repository appropriate to the materials. In particular, repositories that provide permanent identifiers and have robust preservation policies will help to ensure the long-term integrity of published research.

The policy of the Journal of Radiotherapy in Practice is to encourage submissions of replication studies, particularly of research published in this journal.

All data, program code and other methods should be appropriately cited. Such materials should be recognised as original intellectual contributions and afforded recognition through citation.

  • All data sets and program code used in a publication should be cited in the text and listed in the reference section.
  • References for data sets and program code should include a persistent identifier, such as a digital object identifier (DOI). Persistent identifiers ensure future access to unique published digital objects, such as a text or data set. Persistent identifiers are assigned to data sets by digital archives, such as institutional repositories and partners in the Data Preservation Alliance for the Social Sciences (Data-PASS).
  • Data set citation example: Campbell, Angus and Robert L. Kahn. American National Election Study, 1948. ICPSR07218-v3. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 1999.

Open Access

Journal of Radiotherapy in Practice also offers authors the option to publish their work under a Gold Open Access model. For details of our policy and pricing, please click here

Cambridge Journals Language Editing Service

We suggest that authors whose first language is not English have their manuscripts checked by a native English speaker before submission. This is optional but will help to ensure that any submissions that reach peer review can be judged exclusively on academic merit. We offer a Cambridge service which you can find out more about here, and suggest that authors make contact as appropriate. Please note that use of language editing services is voluntary and at the author’s own expense. Use of these services does not guarantee that the manuscript will be accepted for publication nor does it restrict the author to submitting to a Cambridge-published journal.

Information for peer reviewers

For resources about peer review, including guides on how to peer review journal articles and book proposals, in addition to information on ethics in peer review, OPRS blinding, and Publons, please visit our ‘Information for Peer Reviewers’ page.


Journal of Radiotherapy in Practice now requires that all corresponding authors identify themselves using their ORCID iD when submitting a manuscript to the journal. ORCID provides a unique identifier for researchers and, through integration in key research workflows such as manuscript submission and grant applications, provides the following benefits:

  • Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you’ve authored.
  • Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
  • Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.

If you don’t already have an iD, you’ll need to create one if you decide to submit a manuscript to Journal of Radiotherapy in Practice. You can register for one directly from your user account on Editorial Manager or via If you already have an iD, please use this when submitting, either by linking it to your Editorial Manager account or supplying it during submission by using the “Link to ORCID record” button.

Last updated 12 June 2019